RTI Biologics, Inc. (RTIX) Misses Q2 EPS by 3c; Issues Mixed Outlook
Tweet Send to a Friend
RTI Biologics, Inc. (NASDAQ: RTIX) reported Q2 EPS of $0.00, $0.03 worse than the analyst estimate of $0.03. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
